Literature DB >> 9438632

Laparoscopic versus open cholecystectomy in cirrhotic patients: a prospective study.

M A Yerdel1, C Koksoy, N Aras, K Orita.   

Abstract

The results of open cholecystectomy ([OC] n = 7) versus laparoscopic cholecystectomy ([LC] n = 7) in cirrhotic patients were analyzed prospectively. Groups were well matched for surgical indication, presence of ascites/bleeding tendency, and Child's grade. There was no mortality. Mean operating time was significantly longer in the LC group (155 +/- 47 vs. 103 +/- 25 min, p < 0.05). Operative blood loss was significantly greater in the OC group (128 +/- 125 vs. 642 +/- 467 ml, p < 0.05). No patient in LC group required blood transfusion in contrast to three patients in OC group. Compared with 0% postoperative complications in LC group, wound infections developed in 43% of the patients in OC group (p < 0.05). Mean hospital stay in LC group was significantly less (6.7 +/- 4 vs. 17.4 +/- 7.3 days, p < 0.01). Thus, contrary to previous belief, cirrhosis per se is not a contraindication to LC. Laparoscopic cholecystectomy may be the procedure of choice whenever cholecystectomy is indicated in a cirrhotic patient because it may be associated with less bleeding and fewer incision-related complications.

Entities:  

Mesh:

Year:  1997        PMID: 9438632

Source DB:  PubMed          Journal:  Surg Laparosc Endosc        ISSN: 1051-7200


  17 in total

1.  A randomized controlled trial of laparoscopic versus open cholecystectomy in patients with cirrhotic portal hypertension.

Authors:  Wu Ji; Ling-Tang Li; Zhi-Ming Wang; Zhu-Fu Quan; Xun-Ru Chen; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

Review 2.  Gallstones in chronic liver disease.

Authors:  Michael Anthony Silva; Terence Wong
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

3.  Management of common bile duct stones in cirrhotic patients with coagulopathy: a comparison of supra-papillary puncture and standard cannulation technique.

Authors:  Everson L A Artifon; Eduardo B da Silveira; Dayse Aparicio; Jonas Takada; Renato Baracat; Christiano M Sakai; Ruel T Garcia; Vanessa Teich; Decio S Couto
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

4.  Cirrhosis is not a contraindication to laparoscopic cholecystectomy: results and practical recommendations.

Authors:  Kevin Tri Nguyen; Krit Kitisin; Jennifer Steel; Geetha Jeyabalan; Shushma Aggarwal; David A Geller; T Clark Gamblin
Journal:  HPB (Oxford)       Date:  2011-01-25       Impact factor: 3.647

5.  Risk factors for nonhepatic surgery in patients with cirrhosis.

Authors:  Juan A del Olmo; Blas Flor-Lorente; Blas Flor-Civera; Felicidad Rodriguez; Miguel A Serra; Amparo Escudero; Salvador Lledó; José M Rodrigo
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

6.  Laparoscopic cholecystectomy in cirrhotic patients: feasibility in a developing country.

Authors:  Mohammad Tayeb; Muhammad R Khan; Nazia Riaz
Journal:  Saudi J Gastroenterol       Date:  2008-04       Impact factor: 2.485

7.  Bleeding complications in laparoscopic cholecystectomy: Incidence, mechanisms, prevention and management.

Authors:  Robin Kaushik
Journal:  J Minim Access Surg       Date:  2010-07       Impact factor: 1.407

Review 8.  Laparoscopic cholecystectomy in cirrhotic patients.

Authors:  E Cucinotta; S Lazzara; G Melita
Journal:  Surg Endosc       Date:  2003-10-28       Impact factor: 4.584

9.  Laparoscopic cholecystectomy is the preferred approach in cirrhosis: a nationwide, population-based study.

Authors:  David K Chmielecki; Ellen J Hagopian; Yen-Hong Kuo; Yen-Liang Kuo; John M Davis
Journal:  HPB (Oxford)       Date:  2012-10-17       Impact factor: 3.647

10.  Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child-Pugh classification in predicting outcome.

Authors:  Spiros Delis; Andreas Bakoyiannis; Juan Madariaga; John Bramis; Nikos Tassopoulos; Christos Dervenis
Journal:  Surg Endosc       Date:  2009-06-24       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.